Cargando…
Anti-ARHGAP26 Autoantibodies Are Associated With Isolated Cognitive Impairment
Autoantibodies against the RhoGTPase-activating protein 26 (ARHGAP26) were originally identified in the context of subacute autoimmune cerebellar ataxia. Further studies identified a wider clinical spectrum including psychotic, affective, and cognitive symptoms. Only a few patients reported so far h...
Autores principales: | Bartels, Frederik, Prüss, Harald, Finke, Carsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104436/ https://www.ncbi.nlm.nih.gov/pubmed/30158896 http://dx.doi.org/10.3389/fneur.2018.00656 |
Ejemplares similares
-
Two new cases of anti-Ca (anti-ARHGAP26/GRAF) autoantibody-associated cerebellar ataxia
por: Jarius, Sven, et al.
Publicado: (2013) -
Untreated anti-Ca/ARHGAP26 autoantibody-associated cerebellar ataxia progressing over 27 years
por: Schegk, E., et al.
Publicado: (2023) -
Rho GTPase-activating protein 17 (ARHGAP17) as additional autoimmune target in ARHGAP26-IgG/anti-Ca autoantibody-associated autoimmune encephalitis
por: Jarius, Sven, et al.
Publicado: (2022) -
Neuronal autoantibodies associated with cognitive impairment in melanoma patients
por: Bartels, F, et al.
Publicado: (2019) -
High frequency of cerebrospinal fluid autoantibodies in patients with seizures or epilepsies of unknown etiology
por: Schulz, Paulina, et al.
Publicado: (2023)